Physician
Pediatric Rheumatology
Dr. Bradley J. Bloom, MD
|
|
Give Review
Bradley Bloom practices Pediatric Rheumatology. He researched medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He over the years received 1 awards: "Fellow (FACR)". Bradley Bloom has written publications. He has 28 publications published with PubMed. The lastest paper is: 'Felty syndrome complicating juvenile rheumatoid arthritis.' He accepts all Medicare patients.
Publications
- Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
- Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis.
- Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review.
- The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage ...
- Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: comment on the article by Blessing et al.
- Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2002. A 17-year-old boy with acute mitral regurgitation and pulmonary...
- Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.
- Neurocognitive abnormalities in children after classic manifestations of Lyme disease.
- Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: res...
- Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis.
- Magnetic resonance imaging in staphylococcal osteomyelitis with negative bone scan.
- Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy.
- New drug therapies for the pediatric rheumatic diseases.
- Felty syndrome complicating juvenile rheumatoid arthritis.
- von Willebrand factor in juvenile dermatomyositis.
- Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.
- Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis.
- Bicipital synovial cysts in juvenile rheumatoid arthritis: clinical description and sonographic correlation.
- Soluble adhesion molecules in juvenile rheumatoid arthritis.
- Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis.
- Soluble adhesion molecules in pediatric rheumatic diseases.
- Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis.
- Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
- Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.
- Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.
- A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
Schools
NWU FIENBERG SCH OF MED
New England Med Center Hosps
Doctors Specialties
- Pediatric Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
Education
-
Tufts Medical Center -
Northwestern University Feinberg School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1780902585 | |
| NPPES Provider LastName | BLOOM | |
| NPPES Provider FirstName | BRADLEY | |
| NPPES Provider ZIPCode | 100222049 | |
| NPPES Provider State | NY | |
| Specialty Description | Dermatology | |
| Total Claim Count | 200.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780902585 |
| Last Name Of The Provider | BLOOM |
| First Name Of The Provider | BRADLEY |
| View All |
Similar Doctors
|
|
Dr. Peter R. Blier, MD
 This Doctor is OpenDoctor Recommended.
|